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A 40-year-old patient with toothache and
shoulder pain for 10 days died without former
known history of cardiac arrhythmias or myo-
cardial infarction (MI) on sleep-related sudden
cardiac death (SCD). The autopsy did not
reveal signs for traumatic violence or intoxi-
cations nor for acute/chronic infections particu-
larly of the upper aerodigestive tract.
Furthermore, no aspects of endo-/myocarditis
including negative results for cardiotropic virus
were evident.
In contrast, the right ventricular (RV) myocar-
dium showed a diffuse replacement by fatty
tissue (.70%) and dystrophy of cardiomyocytes
(Panel A, arrows indicate endocardium),
corresponding to an arrhythmogenic RV
dysplasia (ARVD) with immunohistochemical
up-regulation of the cytoskeleton protein
desmin (Panel A, inset) and electronmicroscopic
detection of abnormal desmosomes (Panel B, arrowheads and inset). Moreover, the proximal right coronary arteria showed an iso-
lated high-grade stenosis (80%) with acute subtotal thrombotic obliteration (Panel C, inset histological image) resulting in acute MIs
of subendocardial RV myocardium (Panel D, hypereosinophilic cardiomyocytes without nuclei). Since any signs of backward failure of
the left ventricle such as lung oedema were lacking, we diagnosed an SCD due to acute RV failure in a patient with ARVD and acute MI.
ARVD is behind hypertrophic concentric cardiomyopathy the major non-ischaemic cause for SCD in association with sports activity
in young patients (age ,40 years). Here, we describe, to our knowledge, the ﬁrst case of an ARVD in combination with coronary
heart disease/MIs, which might have triggered acute ventricular arrhythmias/failure independently from physical exertion and
should be therefore considered for in vivo/autopsy investigations in family members of ARVD patients.
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